POINT Biopharma Global Inc.
SEC Filing List
PNT CIK: 0001811764
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 15-12G | Notice of termination of registration of... | Point Biopharma Global Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 01/08/2024 | |
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 12/29/2023 | ||
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 12/29/2023 | ||
| S-8 POS | Post-effective amendment to a S-8 regist... | Point Biopharma Global Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 12/27/2023 | |
| S-8 POS | Post-effective amendment to a S-8 regist... | Point Biopharma Global Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 12/27/2023 | |
| 25-NSE | Notification filed by national security ... | Nasdaq Stock Market LLC /fa | 12/27/2023 | ||
| 8-K | Current report filing | Point Biopharma Global Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 12/27/2023 | |
| POS AM | Post-effective amendment to a registrati... | Point Biopharma Global Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 12/27/2023 | |
| POS AM | Post-effective amendment to a registrati... | Point Biopharma Global Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 12/27/2023 | |
| SC 13D/A | Amendment to Schedule filed to report ac... | Silber Allan C | Toppan Merrill/FA /fa | 12/27/2023 | |
| No record found. | |||||
| Load More | |||||
